Protection of pharmaceutical innovation in Europe - Data exclusivity & Roche Bolar

FORUM Institute of Management organises an international conference on the new intellectual property rights after the implementation of the Directive 2004/27/EC.
Especially topics as the new data exclusivity scheme and the implementation of Roche Bolar will be addressed by:
Ian Dodds-Smith, Arnold & Porter LLP, London;
Dr. John Lisman, Medicines Evaluation Board, Den Haag;
Dorthe Poulsen, The Danish Medicines Agency, København;
Burkhard Sträter, law firm Sträter, Bonn

For further information please check
http://www.forum-institut.de/sites/veranstaltung.asp?SemNr=0605238

or contact
Dr. Henriette Wolf-Klein
Deputy head Pharma
FORUM Institute of Management, Heidelberg
Vangerowstraße 18
69115 Heidelberg

Tel. 0049 6221 500 680
Fax. 00 49 6221 500 618
h.wolf-klein@forum-institut.de

FORUM Institute is very active and acknowledged in the field of educational seminars and conferences for the pharmaceutical industry. In several areas FORUM has the leading market position. Especially the close co-operation with the regulatory authorities assures the outstanding quality and up-to-dateness of the trainings. Each novel important guideline from the national authorities or the EMEA/CPMP results in a seminar within a short period of time to insure that pharmaceutical industry personnel receives the proper information and training. The speakers are experts from the pharmaceutical industry, service provider, lawyers and national / international authorities.

This release was published on openPR.